Literature DB >> 15061254

Olanzapine-induced QTc prolongation in a patient with Wolff-Parkinson-White syndrome.

Kuan-Pin Su, Hsien-Yuan Lane, Chiao-Lin Chuang, Kun-Po Chen, Winston W Shen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15061254     DOI： 10.1016/S0920-9964(03)00182-8

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  3 in total

Review 1.  The QT interval and psychotropic medications in children: recommendations for clinicians.

Authors:  Paul McNally; Fiona McNicholas; Paul Oslizlok
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-08-29       Impact factor: 4.785

2.  Absence of cardiac side effects during treatment of schizophrenia with risperidone in a patient with wolff-Parkinson-white syndrome.

Authors:  Fabrice Bon; Eric Louis Constant; Peter Goethals; Daniel Neu
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

Review 3.  QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.

Authors:  Mehrul Hasnain; W Victor R Vieweg
Journal:  CNS Drugs       Date:  2014-10       Impact factor: 5.749
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.